Mouse models of acute and chronic hepacivirus infection
Author(s) -
Eva Billerbeck,
Raphael Wolfisberg,
Ulrik Fahnøe,
Jing Xiao,
Corrine Quirk,
Joseph M. Luna,
John M. Cullen,
Alex S. Hartlage,
Luis Chiriboga,
Kalpana Ghoshal,
W. Ian Lipkin,
Jens Bukh,
Troels K. H. Scheel,
Amit Kapoor,
Charles M. Rice
Publication year - 2017
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aal1962
Subject(s) - virus , immune system , immunology , hepatitis c virus , virology , chronic hepatitis , chronic infection , medicine , hepacivirus , biology
An estimated 71 million people worldwide are infected with hepatitis C virus (HCV). The lack of small-animal models has impeded studies of antiviral immune mechanisms. Here we show that an HCV-related hepacivirus discovered in Norway rats can establish high-titer hepatotropic infections in laboratory mice with immunological features resembling those seen in human viral hepatitis. Whereas immune-compromised mice developed persistent infection, immune-competent mice cleared the virus within 3 to 5 weeks. Acute clearance was T cell dependent and associated with liver injury. Transient depletion of CD4 + T cells before infection resulted in chronic infection, characterized by high levels of intrahepatic regulatory T cells and expression of inhibitory molecules on intrahepatic CD8 + T cells. Natural killer cells controlled early infection but were not essential for viral clearance. This model may provide mechanistic insights into hepatic antiviral immunity, a prerequisite for the development of HCV vaccines.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom